FOLD
Price
$10.59
Change
-$0.00 (-0.00%)
Updated
Oct 2 closing price
33 days until earnings call
IKNA
Price
$1.68
Change
-$0.00 (-0.00%)
Updated
Oct 2 closing price
34 days until earnings call
Ad is loading...

FOLD vs IKNA

Header iconFOLD vs IKNA Comparison
Open Charts FOLD vs IKNABanner chart's image
Amicus Therapeutics
Price$10.59
Change-$0.00 (-0.00%)
Volume$2.07M
CapitalizationN/A
Ikena Oncology
Price$1.68
Change-$0.00 (-0.00%)
Volume$44.08K
CapitalizationN/A
View a ticker or compare two or three
FOLD vs IKNA Comparison Chart
Loading...
FOLD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IKNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
FOLD vs. IKNA commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a Buy and IKNA is a StrongSell.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (FOLD: $10.59 vs. IKNA: $1.68)
Brand notoriety: FOLD and IKNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FOLD: 82% vs. IKNA: 71%
Market capitalization -- FOLD: $3.18B vs. IKNA: $82.52M
FOLD [@Biotechnology] is valued at $3.18B. IKNA’s [@Biotechnology] market capitalization is $82.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whileIKNA’s FA Score has 0 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • IKNA’s FA Score: 0 green, 5 red.
According to our system of comparison, IKNA is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 3 TA indicator(s) are bullish while IKNA’s TA Score has 2 bullish TA indicator(s).

  • FOLD’s TA Score: 3 bullish, 6 bearish.
  • IKNA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, FOLD is a better buy in the short-term than IKNA.

Price Growth

FOLD (@Biotechnology) experienced а -2.67% price change this week, while IKNA (@Biotechnology) price change was -1.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.48%. For the same industry, the average monthly price growth was +0.22%, and the average quarterly price growth was -7.60%.

Reported Earning Dates

FOLD is expected to report earnings on Nov 05, 2024.

IKNA is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+0.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOLD($3.18B) has a higher market cap than IKNA($82.5M). IKNA YTD gains are higher at: -14.721 vs. FOLD (-25.370). FOLD has higher annual earnings (EBITDA): -40.33M vs. IKNA (-71.34M). FOLD has more cash in the bank: 260M vs. IKNA (145M). IKNA has less debt than FOLD: IKNA (9.09M) vs FOLD (444M). FOLD has higher revenues than IKNA: FOLD (456M) vs IKNA (1.84M).
FOLDIKNAFOLD / IKNA
Capitalization3.18B82.5M3,850%
EBITDA-40.33M-71.34M57%
Gain YTD-25.370-14.721172%
P/E RatioN/AN/A-
Revenue456M1.84M24,729%
Total Cash260M145M179%
Total Debt444M9.09M4,883%
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
31

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FOLDIKNA
RSI
ODDS (%)
N/A
Bearish Trend 7 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 14 days ago
76%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
FOLD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IKNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMFPX9.670.08
+0.83%
Westwood Salient MLP & Engy Infras C
CFNCX85.060.12
+0.14%
American Funds Fundamental Invs 529C
MRGSX24.440.03
+0.12%
BlackRock Advantage Global R
PZHEX12.60N/A
N/A
T. Rowe Price Hedged Equity Z
FGTNX22.43N/A
N/A
Fidelity Advisor Global Equity Inc C

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with NTLA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-0.66%
NTLA - FOLD
50%
Loosely correlated
-3.39%
DNLI - FOLD
50%
Loosely correlated
+1.26%
RCKT - FOLD
50%
Loosely correlated
-0.93%
ROIV - FOLD
48%
Loosely correlated
-0.79%
TVTX - FOLD
48%
Loosely correlated
-0.86%
More

IKNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKNA has been closely correlated with ATRA. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IKNA jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
-1.18%
ATRA - IKNA
71%
Closely correlated
-0.26%
AMLX - IKNA
54%
Loosely correlated
-0.98%
FOLD - IKNA
40%
Loosely correlated
-0.66%
JAZZ - IKNA
38%
Loosely correlated
+0.61%
VNDA - IKNA
38%
Loosely correlated
+1.10%
More